These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 4197635)
1. Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals. Hardman HF; Haavik CO; Seevers MH Toxicol Appl Pharmacol; 1973 Jun; 25(2):299-309. PubMed ID: 4197635 [No Abstract] [Full Text] [Related]
2. Acute toxicity and gross behavioral effects of amphetamine, four methoxyamphetamines, and mescaline in rodents, dogs, and monkeys. Davis WM; Bedford JA; Buelke JL; Guinn MM; Hatoum HT; Waters IW; Wilson MC; Braude MC Toxicol Appl Pharmacol; 1978 Jul; 45(1):49-62. PubMed ID: 99845 [No Abstract] [Full Text] [Related]
3. Acute effects of mescaline HCl on behavior, resistance, and endocrine function of male mice. Sackler AM; Weltman AS; Johnson L Exp Med Surg; 1971; 29(1):118-27. PubMed ID: 5147592 [No Abstract] [Full Text] [Related]
4. Pharmacological studies on new potent central depressants, 8-chloro-6-phenyl-4H-s-triazolo [4,3a][1,4] benzodiazepine (D-40tA) and its 1-methyl analogue (D-65MT). Nakajima R; Take Y; Moriya R; Saji Y; Yui T; Nagawa Y Jpn J Pharmacol; 1971 Aug; 21(4):497-516. PubMed ID: 5000774 [No Abstract] [Full Text] [Related]
5. Differences in tolerance to mescaline produced by peripheral and direct central administration. Tilson HA; Sparber SB Psychopharmacologia; 1971; 19(4):313-23. PubMed ID: 5109405 [No Abstract] [Full Text] [Related]
6. Fluotracen: a tricyclic compound with the combined properties of antidepressants and antipsychotics in animals. Fowler PJ; Zirkle CL; Macko E; Setler PE; Sarau HM; Misher A; Tedeschi DH Arzneimittelforschung; 1977; 27(8):1589-95. PubMed ID: 410422 [No Abstract] [Full Text] [Related]
7. General and behavioral pharmacology. Harris LS Pharmacol Rev; 1971 Dec; 23(4):285-94. PubMed ID: 4943947 [No Abstract] [Full Text] [Related]
8. Mescaline and related compounds. Patel AR Fortschr Arzneimittelforsch; 1968; 11():11-47. PubMed ID: 4873202 [No Abstract] [Full Text] [Related]
9. Stimulus properties of mescaline and N-methylated derivatives: difference in peripheral and direct central administration. Browne RG; Harris RT; Ho BT Psychopharmacologia; 1974; 39(1):43-56. PubMed ID: 4425137 [No Abstract] [Full Text] [Related]
11. Effects of some substituted phenanthrenes on the central nervous system. Roszkowski AP; Schuler ME; Nelson PH J Med Chem; 1972 Dec; 15(12):1336-8. PubMed ID: 4635985 [No Abstract] [Full Text] [Related]
12. Brain levels of serotonin (5-HT) and norepinephrine (NE) during mescaline-induced behavior in mice. Shah NS Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):201-4. PubMed ID: 4686103 [No Abstract] [Full Text] [Related]
13. [Contribution on the pharmacology of gamma-butyrolactone]. Hampel H; Hapke HJ Arch Int Pharmacodyn Ther; 1968 Feb; 171(2):306-22. PubMed ID: 5685835 [No Abstract] [Full Text] [Related]
14. Inhibition of isolation-induced attack behavior of mice by drugs. Uyeno ET J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276 [No Abstract] [Full Text] [Related]
15. A comparison of the effect of mescaline on activity and emotional defaecation in seven strains of mice. Lush IE Br J Pharmacol; 1975 Sep; 55(1):133-9. PubMed ID: 1182341 [TBL] [Abstract][Full Text] [Related]
16. Influence of psychotropic drugs and beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice. Shah NS Biochem Pharmacol; 1976 Mar; 25(5):591-7. PubMed ID: 8055 [No Abstract] [Full Text] [Related]